Association of Mthfr C677t Polymorphism With Elevated Homocysteine Level and Disease Development in Vitiligo Publisher Pubmed



Bagheri Hamidi A¹ ; Namazi N¹ ; Mohammad Amoli M² ; Amani M¹ ; Gholami M² ; Youssefian L^{3, 4, 5} ; Vahidnezhad H^{4, 5} ; Abdollahimajd F^{1, 6} ; Uitto J^{4, 5} Show Affiliations
Source: International Journal of Immunogenetics Published:2020

Abstract

Increasing evidence on the association of MTHFR gene polymorphism and serum homocysteine levels with autoimmune diseases such as vitiligo has made the MTHFR gene a very interesting candidate to be evaluated in different ethnicities and populations. We aimed to evaluate the levels of serum homocysteine and vitamin B12 and their associations with MTHFR C677T polymorphism in the Iranian population. This case–control study included 104 patients with vitiligo and 100 age- and sex-matched healthy control subjects. Serum vitamin B12 and homocysteine levels were measured by a chemiluminescence assay. Polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) analysis was used for genotyping the polymorphism. The mean serum homocysteine levels were significantly higher in cases than controls and associated with disease activity (p <.001). Furthermore, the homozygous MTHFR C677T variant genotype was associated with vitiligo development (adjusted OR: 3.52, 95% CI: 1.09–11.32, p =.02) and elevated homocysteine level (p <.001). There was no association between serum vitamin B12 levels and the MTHFR C677T genotype. The homozygous variant MTHFR C677T may be considered as a risk factor for both elevated homocysteine levels and the development of vitiligo in the Iranian population. Although these results are not conclusive, they could elucidate the contribution of genetic and immune-mediated inflammatory factors to the pathogenesis of vitiligo. © 2020 John Wiley & Sons Ltd